Gallardo family expand ownership of Almirall

The Gallardo Family, the main shareholders of the listed Spanish pharmaceutical company Almirall (ALM: MC), today announced to the Spanish Regulator the acquisition of 8.45% of the shares of the company that were in the hands of Daniel Bravo Andreu.

This acquisition was carried out in an indirect manner through which Grupo Corporativo Landon (the business holding company of the Gallardo Family) acquired a third of the corporate structure through which Messrs. Jorge and Antonio Gallardo, together with Mr Bravo, jointly and in joint action controlled 25.34% of the shares through the company TODASA.

After this operation, Messrs. Gallardo went on to control 66.64% of the shares of Almirall, which is Spain’s largest drugmaker, and Mr Bravo keeps his shareholding in person as well as the position in the board of directors of the company; the remaining 33.1% is diversified as a Free float in the Spanish stock exchange. The Free float, therefore, does not change.